At the molecular level, activation of the nuclear factor of kappa light polypeptide gene enhancer in B-cells (NFKB) signaling pathway has been identified as important mechanism for HL pathogenesis [30]. The gene discussed is NFKB1; the disease is Hodgkins lymphoma.